Welcome to our dedicated page for Astrotech news (Ticker: ASTC), a resource for investors and traders seeking the latest updates and insights on Astrotech stock.
Astrotech Corporation develops instrumentation businesses built around mass spectrometry and gas chromatography technologies through wholly owned subsidiaries. News about ASTC commonly covers 1st Detect and its TRACER 1000 trace detection systems for aviation security, explosives screening, and narcotics detection, including regulatory certifications, deployments, and security-market applications.
Company updates also address AgLAB process analyzers for agriculture products, Pro-Control industrial chemical process control, BreathTech breath-analysis work for volatile organic compounds, and EN-SCAN portable environmental GC-MS for field testing of air, water, and soil. Recurring releases include fiscal results, research and development progress, sales activity, leadership appointments, and board-level strategic or governance actions.
Astrotech (Nasdaq: ASTC) reported results for the third quarter of fiscal 2026, ended March 31, 2026. Research and development expense was $554 thousand, described as a 28% decline as the company transitions from development to saleable EN-SCAN Handheld GC and 1st Detect TRACER 1000 products.
Through March 31, 2026, the TRACER 1000 trace detection system had been deployed in about 37 locations across 16 countries in the United States, Europe and Asia, supporting commercialization efforts and customer engagement in industrial, safety and trace detection markets.
Astrotech (Nasdaq: ASTC) announced that its 1st Detect TRACER 1000 has received ECAC/EU G1 approval, meeting the highest European standards for aviation trace detection security.
The mass spectrometry-based system is field proven, with deployments in 16 countries, and includes an expandable threat library to address evolving security risks.
Astrotech (Nasdaq: ASTC) reported second-quarter fiscal 2026 results for the period ended December 31, 2025. R&D expense fell to $1,832 thousand, a 25% decline year-over-year as the company shifts from development to saleable products for EN-SCAN Handheld GC and TRACER 1000 lines.
Through Dec. 31, 2025, the company deployed the TRACER 1000 in approximately 35 locations across 16 countries. Management named Scott Bartley Interim CFO and David Spada Director of Global Sales.
Astrotech (Nasdaq: ASTC) announced on Jan 21, 2026 that subsidiary 1st Detect appointed industry veteran David Spada as Director of Global Sales to expand deployment of the TRACER 1000™ mass spectrometry trace detector in international security markets.
Spada brings over a decade of trace-detection experience from Implant Sciences, Morpho Detection, and Rapiscan Systems and previously led trace-detection sales and strategy for the Americas. The hire aims to accelerate commercial adoption of laboratory-grade, field-deployable molecular identification to reduce false alarms and strengthen screening checkpoints.
Astrotech (Nasdaq: ASTC) said its subsidiary 1st Detect is ready to support the U.S. Department of Homeland Security's $1 billion aviation security modernization initiative announced on Nov 22, 2025. 1st Detect offers the TRACER 1000™ mass spectrometry detection system, approved for TSA air cargo screening and by the European Civil Aviation Conference, and operational at international airports and U.S. cargo facilities.
The company noted TRACER 1000 has not yet been deployed at U.S. passenger checkpoints but said its Austin production facility can scale immediately to meet anticipated demand.
Astrotech Corporation (Nasdaq: ASTC) announced on Nov 19, 2025 that its Board of Directors has initiated a review of strategic alternatives to explore ways to maximize shareholder value. The review may include raising equity capital, reverse mergers, combination transactions, sale of all or part of the business, and other strategic or financial transactions.
The company said it continues to advance sales plans and customer relationships in explosives and narcotics trace detection, security screening, environmental testing and industrial controls. Astrotech has not set a deadline for the review, gave no assurance a transaction will occur, and does not intend further comment unless the Board decides additional disclosure is appropriate.
Astrotech (Nasdaq: ASTC) reported results for Q1 FY2026, quarter ended Sept 30, 2025. Revenue rose to $297,000, a 35% increase versus Q4 FY2025 driven by 1st Detect grant revenue and higher consumables sales. As of Sept 30, 2025, the company has deployed the TRACER 1000 in ~34 locations across 16 countries. The board appointed Nihanth Badugu as COO effective Aug 13, 2025. Consolidated cash and liquid investments totaled $13.9 million, which the company says will support R&D, organic growth, and potential acquisitions. Management highlighted traction in transportation, cargo screening, narcotics and explosives detection, and environmental testing as a platform for sales acceleration in 2026.
Astrotech Corporation (Nasdaq: ASTC) appointed Scott Bartley as Interim Chief Financial Officer, effective October 20, 2025. Bartley is a Certified Public Accountant and Certified Valuation Analyst with over two decades of finance experience across public and private companies and industries including technology, manufacturing, pharmaceuticals and broker‑dealer operations.
His background includes consulting (since 2011), roles at Bridgepoint Consulting, prior CFO positions, ownership of advisory firms, CFO of Westlake Securities (2008–2011), and Assurance Senior Manager at Deloitte & Touche. He holds a BBA and a Master of Professional Accounting from the University of Texas at Austin.
Astrotech (NASDAQ:ASTC) reported its fiscal year 2025 results, showing a decrease in revenue to $1.0 million due to lower device sales at its 1st Detect subsidiary. The company maintained a slight improvement in gross margin at 45.3% compared to 45.1% in the previous year.
Key developments include the formation of EN-SCAN, a new subsidiary for environmental testing, the launch of an enhanced TRACER 1000 Narcotics Trace Detector, and securing a DHS research contract. The TRACER 1000 is now deployed in 34 locations across 16 countries. The company maintains a strong financial position with $18.2 million in cash and investments as of June 30, 2025.
Astrotech Corporation (NASDAQ: ASTC) has appointed Nihanth Badugu as its new Chief Operating Officer, effective August 13, 2025. Badugu, 37, previously served as Astrotech's Director of Program Management since August 2023, where he led initiatives to enhance operational efficiency.
Prior to joining Astrotech, Badugu held positions at Thermo Fisher Scientific as NPI Program Manager (2020-2023), where he led COVID-19 diagnostic products launches, and served as Senior Program Manager at PVA Consulting Group (2017-2020). He holds a Bachelor of Science degree from York University.